.jpg)
METHOD FOR THE DIAGNOSIS OF A CORONAVIRUS INFECTION
WO2022195037A1
The present invention can be included in the medical field. Particularly, the present invention refers to an in vitro method for the diagnosis of a coronavirus infection which is preferably carried out by using minimally-invasive biological samples obtained from the subject, most preferably plasma samples.
The inventors of the present invention consider that the cytokine profile plays an important role in the pathogenesis of hospitalized patients and, consequently, finding a specific cytokine profile could be of utmost importance for performing an early diagnosis of the coronavirus infection, thus giving rise to the possibility of administering targeted treatments in an early stage of the disease. Hence, the inventors of the present invention have identified a cytokine fingerprint that allows an early diagnosis of COVID-19. It is also important to note that the present invention is implemented in by using minimally-invasive biological samples obtained from the subject, preferably plasma samples.
Powerful in vitro method for the diagnosis of a coronavirus infection that is preferably carried out through the use of minimally invasive biologicals samples obtained from the subject,